GENB
Generate Biomedicines, Inc.
13.49
-0.29 (-2.10%)
52w low 11.00
22.67 high
21.3% of range
Financial Analysis
| (USD) | Mar 25 | Jun 25 | Mar 26 | Jun 26 | Trend |
|---|---|---|---|---|---|
| Total Revenue | 8.82M | 10.13M | 7.22M | 6.31M | |
| Operating Expenses | 56.97M | 70.28M | 71.34M | 77.93M | |
| R&D | 46.83M | 59.73M | 57.81M | 64.33M | |
| SG&A | 10.15M | 10.54M | 13.52M | 13.60M | |
| Operating Income | -48.15M | -60.15M | -64.11M | -71.61M | |
| EBITDA | -40.48M | -53.07M | -58.23M | -63.82M | |
| Pretax Income | -44.26M | -56.70M | -61.69M | -67.20M | |
| Income Tax | 56.00K | 44.00K | 28.00K | 53.00K | |
| Net Income | -41.69M | -52.43M | -61.45M | -67.25M | |
| EPS Diluted | -0.52 | -0.63 | -1.07 | -0.52 | |
| Diluted Shares | 102.31M | 102.31M | 64.87M | 128.24M |
Revenue CAGR
-10.5%
Net Income CAGR
--
EPS CAGR
--
FCF CAGR
--
Revenue YoY
-12.6%